Clinical Trials Logo

Clinical Trial Summary

To compare the effectiveness of vaginal dinoprostone and vaginal misoprostol with placebo in minimizing the pain experienced by postmenopausal patients during diagnostic office hysteroscopy and to assess the ease of insertion of hysteroscope as reported by the hysteroscopist.


Clinical Trial Description

hysteroscopy is commonly used in the diagnosis and treatment of intrauterine lesions such as polyps, fibroids, septa, and adhesions, and in the presence of abnormal bleeding and during the removal of an intrauterine device or foreign body. Cervical ripening is made possible by the use of medication through different routes. The most commonly used agent is misoprostol, a synthetic prostaglandin E1 (PGE1) analog that is frequently administered in off-label use in obstetrics and gynecology for medical abortion, labor induction, endometrial biopsy, dilatation and curettage, intrauterine device insertion, myomectomy, postpartum hemorrhage, and cervical ripening. In contrast, dinoprostone, a natural PGE2, is mostly used in obstetrics for cervical ripening and the stimulation of uterine contractions to induce labor. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04044079
Study type Interventional
Source Cairo University
Contact
Status Completed
Phase Phase 4
Start date August 20, 2019
Completion date February 10, 2020

See also
  Status Clinical Trial Phase
Completed NCT03683914 - Vaginal Dinoprostone Prior to Diagnostic Office Hysteroscopy in Postmenopausal Patients Phase 4
Completed NCT05610371 - Intrauterine Anesthesia in Operative, Awake, Office Hysteroscopy. A Randomized Double-blind Placebo-controlled Trial N/A
Completed NCT05246436 - Effect of Warm Fluid Distension Media in Relieving Pain in Outpatient Hysteroscopy N/A